Novartis CEO warns reality of Trump’s drug pricing policy will set in over ‘the next 18 months’

by | April 28, 2026 1:11 pm | US Markets

Novartis’ CEO warned Tuesday that U.S. drug pricing policy under President Donald Trump poses a “very difficult situation.”